Data are from the largest multi-institutional study on robotic-assisted radical cystectomy (RARC) with totally intracorporeal neobladder urinary diversion.

On a quest to bring its multiple myeloma antibody-drug conjugate Blenrep back to the U.S. | Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with ocular toxicity side effects, ...

Oncologic Drugs Advisory Committee (ODAC) has voted against the benefit/risk profile of GSK’s Blenrep (belantamab mafodotin) ju ...

The British pharmaceutical company said combinations for its Blenrep drug were evaluated in adults with relapsed or refractory multiple myeloma who have previously received at least one line of ...

TriSalus Life Sciences® Inc. (Nasdaq: TLSI) ("TriSalus" or the "Company"), a company working to improve outcomes for patients with solid tumors by combining innovative drug delivery, today announced ...

Dr. Michael Weber brings expertise in spine oncologic surgery to UConn Health Dr. Michael Weber is an internationally ...

The FDA's Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple myeloma patient population.

Web sites of 29 safety net care coordination programs in 22 states were identified; 62% (n = 18) offered oncologic services. Programs were in 65% (n = 11) of states that did not expand Medicaid. Of ...

Background: Oncologic and functional outcomes after radical prostatectomy (RP) can vary between surgeons to a greater extent than is expected by chance. We sought to examine the effects of surgeon ...

Traditionally, in Chile, oncologic patients (OPs) were considered poor candidates for intensive care unit (ICU) admission, and exclusion of these patients from ICU care was a common practice. 4, 5 ...

Oncologic randomized clinical trials published between 2003 and 2018 exhibited a low rate of female corresponding authorship in relation to the overall percentage of female academic oncologists ...